Armo Biosciences Inc. (ARMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2018 | 12-2017 | 03-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,722 | N/A | -9,396 | -33,620 | -27,470 |
| Depreciation Amortization | 52 | N/A | 52 | 200 | 200 |
| Accounts payable and accrued liabilities | 821 | N/A | -3,291 | 0 | 0 |
| Other Working Capital | 2,233 | N/A | -1,744 | 4,110 | 1,090 |
| Other Operating Activity | 81 | 0 | 3,478 | 940 | 580 |
| Operating Cash Flow | $-18,535 | $N/A | $-10,901 | $-28,370 | $-25,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -137 | N/A | N/A | -100 | -80 |
| Investing Cash Flow | $-137 | $N/A | $N/A | $-100 | $-80 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 136,896 | N/A | N/A | 0 | 0 |
| Common Stock Repurchased | N/A | N/A | -6 | 0 | 0 |
| Other Financing Activity | -2,386 | 0 | 0 | 9,970 | 54,500 |
| Financing Cash Flow | $134,510 | $N/A | $-6 | $9,970 | $54,500 |
| Beginning Cash Position | 49,525 | N/A | 26,787 | 45,250 | 16,430 |
| End Cash Position | 165,363 | N/A | 15,880 | 26,730 | 45,250 |
| Net Cash Flow | $115,838 | $N/A | $-10,907 | $-18,510 | $28,810 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,535 | N/A | -10,901 | -28,370 | -25,600 |
| Capital Expenditure | -137 | N/A | N/A | 0 | 0 |
| Free Cash Flow | -18,672 | 0 | -10,901 | -28,370 | -25,600 |